| Literature DB >> 33565219 |
Bernard Lanz1,2, Alireza Abaei3, Olivier Braissant4, In-Young Choi5, Cristina Cudalbu6, Pierre-Gilles Henry7, Rolf Gruetter1, Firat Kara8, Kejal Kantarci8, Phil Lee9, Norbert W Lutz10, Małgorzata Marjańska7, Vladimír Mlynárik11, Volker Rasche3, Lijing Xin6, Julien Valette12,13.
Abstract
In vivo MRS is a non-invasive measurement technique used not only in humans, but also in animal models using high-field magnets. MRS enables the measurement of metabolite concentrations as well as metabolic rates and their modifications in healthy animals and disease models. Such data open the way to a deeper understanding of the underlying biochemistry, related disturbances and mechanisms taking place during or prior to symptoms and tissue changes. In this work, we focus on the main preclinical 1H, 31P and 13C MRS approaches to study brain metabolism in rodent models, with the aim of providing general experts' consensus recommendations (animal models, anesthesia, data acquisition protocols). An overview of the main practical differences in preclinical compared with clinical MRS studies is presented, as well as the additional biochemical information that can be obtained in animal models in terms of metabolite concentrations and metabolic flux measurements. The properties of high-field preclinical MRS and the technical limitations are also described.Entities:
Keywords: anesthesia; brain metabolism; consensus review; dynamic MRS; neurochemical profile; preclinical MRS
Year: 2020 PMID: 33565219 PMCID: PMC9429976 DOI: 10.1002/nbm.4325
Source DB: PubMed Journal: NMR Biomed ISSN: 0952-3480 Impact factor: 4.478